User login
Inflammatory bowel disease (IBD) is a term that is used to describe disorders involving chronic inflammation of the digestive tract, such as ulcerative colitis or Crohn’s disease.
In this 4-part video series, a panel of experts discuss diagnosis, identifying moderate or severe IBD patients, treatment, and patient education.
Disclosure: The faculty received modest honoraria from Frontline Medical Communications for their participation in this roundtable and maintained complete editorial control over all content presented. The views of the faculty do not necessarily reflect those of Frontline Medical Communications, the American Gastroenterological Association (AGA), or the sponsor. This video roundtable was produced by the Custom Programs division of Frontline Medical Communications. The editorial staff of GI & Hepatology News was not involved in developing the video roundtable.
Inflammatory bowel disease (IBD) is a term that is used to describe disorders involving chronic inflammation of the digestive tract, such as ulcerative colitis or Crohn’s disease.
In this 4-part video series, a panel of experts discuss diagnosis, identifying moderate or severe IBD patients, treatment, and patient education.
Disclosure: The faculty received modest honoraria from Frontline Medical Communications for their participation in this roundtable and maintained complete editorial control over all content presented. The views of the faculty do not necessarily reflect those of Frontline Medical Communications, the American Gastroenterological Association (AGA), or the sponsor. This video roundtable was produced by the Custom Programs division of Frontline Medical Communications. The editorial staff of GI & Hepatology News was not involved in developing the video roundtable.
Inflammatory bowel disease (IBD) is a term that is used to describe disorders involving chronic inflammation of the digestive tract, such as ulcerative colitis or Crohn’s disease.
In this 4-part video series, a panel of experts discuss diagnosis, identifying moderate or severe IBD patients, treatment, and patient education.
Disclosure: The faculty received modest honoraria from Frontline Medical Communications for their participation in this roundtable and maintained complete editorial control over all content presented. The views of the faculty do not necessarily reflect those of Frontline Medical Communications, the American Gastroenterological Association (AGA), or the sponsor. This video roundtable was produced by the Custom Programs division of Frontline Medical Communications. The editorial staff of GI & Hepatology News was not involved in developing the video roundtable.
